Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Expanded Access Program for Emicizumab in Patients With Hemophilia A With Inhibitors
Conditions
Interventions
Emicizumab
Locations
14
United States
University of Colorado Denver, Children's Hospital
Aurora, Colorado, United States
University of Miami Miller School of Medicine
Miami, Florida, United States
Rush Medical Center
Chicago, Illinois, United States
Tulane Medical Center; Investigational/Research Pharmacy
New Orleans, Louisiana, United States
Boston Childrens Hospital
Boston, Massachusetts, United States
University of Minnesota
Minneapolis, Minnesota, United States
Last Updated
March 29, 2018
NCT07226206
NCT05987449
NCT04645199
NCT06703606
NCT06702579
NCT03818763
Lead Sponsor
Genentech, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions